Trial Profile
A study to evaluate the efficacy of third regimen with vonoprazan for eradication of Helicobacter pylori resistant against first and second regimen.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Feb 2022
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary) ; Amoxicillin; Metronidazole
- Indications Helicobacter pylori infections
- Focus Therapeutic Use
- 22 Feb 2022 Status changed from recruiting to completed.
- 23 Apr 2015 New trial record